UNISON ADVISORS LLC – Supernus Pharmaceuticals, Inc. Transaction History
UNISON ADVISORS LLC portfolio value:
$861,000
portfolio value
UNISON ADVISORS LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +30.46% | 5.93K shares | 298K | $33.85 | 25.42K |
Q2 2022 | share | 0.00% | 0 shares | -67K | $28.92 | 19.48K | |
Q1 2022 | share | 0.00% | 0 shares | 62K | $32.32 | 19.48K | |
Q4 2021 | share | 0.00% | 0 shares | 49K | $30.03 | 19.48K | |
Q3 2021 | share | 0.00% | 0 shares | -81K | $26.67 | 19.48K | |
Q2 2021 | share | 0.00% | 0 shares | 90K | $30.79 | 19.48K | |
Q1 2021 | share | 0.00% | 0 shares | 19K | $26.18 | 19.48K | |
Q4 2020 | share | Increase | 0.00% | 19.48K shares | 491K | $25.16 | 19.48K |